JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB219413

Anti-MyD88 antibody [EPR21824]

Be the first to review this product! Submit a review

|

(76 Publications)

Anti-MyD88 antibody [EPR21824] (ab219413) is a rabbit monoclonal antibody detecting MyD88 in Western Blot, IP. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 40 publications

View Alternative Names

Myeloid differentiation primary response protein MyD88, MYD88

4 Images
Immunoprecipitation - Anti-MyD88 antibody [EPR21824] (AB219413)
  • IP

Supplier Data

Immunoprecipitation - Anti-MyD88 antibody [EPR21824] (AB219413)

MyD88 was immunoprecipitated from 0.35 mg RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate with ab219413 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab219413 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.

Lane 1 : RAW 264.7 whole cell lysate 10 μg (Input).
Lane 2 : ab219413 IP in RAW 264.7 whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab219413 in RAW 264.7 whole cell lysate (-).
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.

All lanes:

Immunoprecipitation - Anti-MyD88 antibody [EPR21824] (ab219413)

Predicted band size: 33 kDa

false

Western blot - Anti-MyD88 antibody [EPR21824] (AB219413)
  • WB

Lab

Western blot - Anti-MyD88 antibody [EPR21824] (AB219413)

Blocking/Dilution buffer : 5% NFDM/TBST.

ab219413 was shown to specifically react with MyD88 in wild-type HAP1 cells as signal was lost in MyD88 knockout cells. Wild-type and MyD88 knockout samples were subjected to SDS-PAGE. ab219413 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique

All lanes:

Western blot - Anti-MyD88 antibody [EPR21824] (ab219413) at 1/100000 dilution

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

MyD88 knockout HAP1 whole cell lysate at 20 µg

Lane 3:

HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 4:

Ramos (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 33 kDa

false

Exposure time: 3min

Western blot - Anti-MyD88 antibody [EPR21824] (AB219413)
  • WB

Supplier Data

Western blot - Anti-MyD88 antibody [EPR21824] (AB219413)

False colour image of Western blot : Anti-MyD88 antibody [EPR21824] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab219413 was shown to bind specifically to MyD88. A band was observed at 35 kDa in wild-type A549 cell lysates with no signal observed at this size in MYD88 knockout cell line ab286715 (knockout cell lysate ab290793). To generate this image, wild-type and MYD88 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-MyD88 antibody [EPR21824] (ab219413) at 1/1000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

MYD88 knockout A549 cell lysate at 20 µg

Lane 2:

Western blot - Human MYD88 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-myd88-knockout-a549-cell-line-ab286715'>ab286715</a>)

Lane 3:

HEK-293 cell lysate at 20 µg

Secondary

Lanes 1 - 3:

Goat anti-Mouse IgG H&L 680RD

Lanes 1 - 3:

Goat anti-Rabbit IgG H&L 800CW

Predicted band size: 33 kDa

Observed band size: 35 kDa

false

Western blot - Anti-MyD88 antibody [EPR21824] (AB219413)
  • WB

Supplier Data

Western blot - Anti-MyD88 antibody [EPR21824] (AB219413)

Blocking/Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-MyD88 antibody [EPR21824] (ab219413) at 1/1000 dilution

Lane 1:

Rat liver lysate at 20 µg

Lane 2:

RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg

Lane 3:

A20 (Mouse reticulum sarcoma B lymphocyte) cell lysate at 20 µg

Lane 4:

Mouse liver lysate at 20 µg

Lane 5:

Mouse lung lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 33 kDa

false

Exposure time: 3min

  • Carrier free

    Anti-MyD88 antibody [EPR21824] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR21824

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-MyD88 antibody [EPR21824] (ab219413) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP) in Human, Mouse, Rat samples.

What is the molecular weight of MyD88?
Anti-MyD88 [EPR21824] (ab219413) specifically detects a band for MyD88 (UniProt: P22366) at a molecular weight of 33kDa.

Trusted by the scientific community
Anti-MyD88 [EPR21824] (ab219413) was first used in a scientific publication in 2018 and has been cited over 40 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-MyD88 antibody [EPR21824] (ab219413) has been confirmed by Western blot testing in MYD88 Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [EPR21824] also available for your convenience: ab219413, Carrier free - ab236766

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MyD88 standing for myeloid differentiation primary response 88 is a cytoplasmic adaptor protein with a molecular weight of approximately 33 kDa. This protein is expressed widely in immune cells including monocytes macrophages and dendritic cells. MyD88 serves a major role in the signaling pathways for the innate immune system. It acts as a linker transmitting signals from toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs) to downstream signaling molecules ultimately activating transcription factors.
Biological function summary

MyD88 plays a significant role in mediating immune responses by forming part of a complex that includes IRAK kinases and TRAF6. When TLRs or IL-1Rs activate MyD88 this adaptor protein recruits IRAK4 which then phosphorylates IRAK1 or IRAK2. This cascade promotes the activation of NF-κB and MAPK pathways leading to the production of inflammatory cytokines. The MyD88-dependent pathway is integral to innate immunity influencing how the body responds to pathogen infection and inflammation.

Pathways

MyD88 integrates into both the TLR signaling and IL-1R signaling pathways. Key related proteins in these pathways include interleukin-1 receptor-associated kinase (IRAK) and tumor necrosis factor receptor-associated factor 6 (TRAF6). MyD88 initiates the recruitment and activation of IRAK1 and IRAK4 following receptor engagement leading to subsequent activation of downstream signals. As part of these pathways MyD88 mediates cellular responses important for immune system signaling and inflammatory response regulation.

MyD88 involvement is notable in the context of oncological and autoimmune diseases. Mutations or dysregulation of MyD88 are implicated in conditions like lymphoma and rheumatoid arthritis. In lymphoma the mutation usually results in constant activation of NF-κB leading to unchecked cell growth. As for rheumatoid arthritis an overactive immune response due to MyD88 can cause additional inflammation affecting joint tissues. In these conditions MyD88 interaction with IRAK4 is significant given their mutual role in immune and inflammatory pathways.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response (PubMed : 15361868, PubMed : 18292575, PubMed : 33718825, PubMed : 37971847). Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed : 15361868, PubMed : 19506249, PubMed : 24316379). Increases IL-8 transcription (PubMed : 9013863). Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Upon TLR8 activation by GU-rich single-stranded RNA (GU-rich RNA) derived from viruses such as SARS-CoV-2, SARS-CoV and HIV-1, induces IL1B release through NLRP3 inflammasome activation (PubMed : 33718825). MyD88-mediated signaling in intestinal epithelial cells is crucial for maintenance of gut homeostasis and controls the expression of the antimicrobial lectin REG3G in the small intestine (By similarity).
See full target information MYD88

Publications (76)

Recent publications for all applications. Explore the full list and refine your search

Drug design, development and therapy 19:6269-6282 PubMed40727923

2025

Integrative Network Pharmacology and Transcriptomics Reveal the Mechanism of Gui-Qi-Yi-Shen Granules in the Treatment of IgA Nephropathy.

Applications

Unspecified application

Species

Unspecified reactive species

Jia-Wei Cao,Yue-Wen Tang,Meng-Ya Jiang,Meng-Dan Lu,Ru-Chun Yang,Dong-Rong Yu,Feng Wan

International journal of molecular medicine 56: PubMed40709387

2025

Bmi1 regulates neural differentiation of mesenchymal stem cells through the Wnt3a‑RhoA signaling pathway to repair ischemic brain injury in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Kunling Chen,Hongjie Zhou,Jie Zhang,Yiwei Zhang,Xiaobing Dou,Qin Yu,Liping Zhou

Inflammation : PubMed40601171

2025

MLKL Modulates Necroptosis and Neuroinflammation in a Mouse Model of MS.

Applications

Unspecified application

Species

Unspecified reactive species

Minjun Xiao,Ge Gao,Jingjing Mu,Qi Sun,Yun Zhao,Xueli Fan

The Korean journal of pain 38:292-307 PubMed40556327

2025

MiR-298 suppresses astrocytic NF-κB activity and neuroinflammation targeting MyD88 in bone cancer pain.

Applications

Unspecified application

Species

Unspecified reactive species

Ming Liu,Denggui Wang,Zhirong Yan,Min Zhou

Diabetology & metabolic syndrome 17:182 PubMed40448159

2025

Gamma -aminobutyric acid ameliorates neurological impairments in type 1 diabetes mellitus mice by regulating the "gut flora-LPS-TLR4-NF-ΚB" signalling Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jiao Wang,Lihai Zhang,Xianhe Wang,Jing Dong,Jiaxin Li

European journal of trauma and emergency surgery : official publication of the European Trauma Society 51:178 PubMed40253667

2025

Immunomodulatory and cardio-protective effects of differentially originated multipotent mesenchymal stroma cells during polymicrobial sepsis in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Anna Kanewska,Ina Lackner,Anne Friedrich,Martina Winkelmann,Markus Rojewski,Birte Weber,Jochen Preßmar,Mario Perl,Hubert Schrezenmeier,Miriam Kalbitz

iScience 27:111488 PubMed39759009

2025

Amitriptyline revitalizes ICB response via dually inhibiting Kyn/Indole and 5-HT pathways of tryptophan metabolism in ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Junyang Li,Bingjie Mei,Lu Feng,Xiaoxin Wang,Dengfeng Wang,Jianming Huang,Guonan Zhang

Journal of biochemical and molecular toxicology 38:e70035 PubMed39552449

2024

Paeonol Alleviates Subarachnoid Hemorrhage Injury in Rats Through Upregulation of SIRT1 and Inhibition of HMGB1/TLR4/MyD88/NF-κB Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zhao Liu,Jun Zhu,Enyu Pan,Lujun Pang,Xiwei Zhou,Yanjun Che

Frontiers in veterinary science 11:1431110 PubMed39329065

2024

Decompression sickness-induced skeletal muscle injury: an animal model and pathological analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Guanghua Chen,Yongbin Huang,Chunman Huang,Liwei Li,Jingqun Pang,Hongqiang Li,Wenxi Zhang

Chemical biology & drug design 104:e14579 PubMed39013775

2024

The protective effect of karanjin against sepsis-induced acute lung injury in mice is involved in the suppression of the TLR4 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chujie Zhang,Juncong Ma,Chang Liu,Xianliang Yan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com